Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio

Go back to Favorable Medicare Coverage Decision Supports Commercial Adoption of iMDx GraftAssure Assay Portfolio
(NASDAQ: IMDX) Delayed: 3.95 +0.37 (10.34%)
Previous Close $3.58    52 Week High
Open $3.67    52 Week Low
Day High $3.98    P/E N/A 
Day Low $3.51    EPS
Volume 197,737